Submissions from 2024
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debu Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown-Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica Stringer-Reasor, Sarah Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle Melisko, Jane Perlmutter, Hope S Rugo, W Fraser Symmans, Laura J Van't Veer, Douglas Yee, Donald A Berry, and Laura J Esserman
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain., Jessica R Allegretti, Krisztina B Gecse, Michael Chiorean, Marjorie Argollo, Xiang Guo, Nervin Lawendy, Chinyu Su, Rajiv Mundayat, Jerome Paulissen, Leonardo Salese, and Peter M Irving
Safety and real-world dosing of onabotulinumtoxinA for the treatment of adult spasticity: post hoc analysis of the Adult Spasticity International Registry study., Ganesh Bavikatte, Alberto Esquenazi, Michael A Dimyan, Khashayar Dashtipour, Wuwei Feng, Angeli Mayadev, Kristina Fanning, Tiziana Musacchio, Aleksej Zuzek, and Gerard E Francisco
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial., Michael Benatar, Thomas Hansen, Dror Rom, Marie A Geist, Thomas Blaettler, William Camu, Magdalena Kuzma-Kozakiewicz, Leonard H van den Berg, Raul Juntas Morales, Adriano Chio, Peter M Andersen, Pierre-Francois Pradat, Dale Lange, Philip Van Damme, Gabriele Mora, Mariusz Grudniak, Matthew Elliott, Susanne Petri, Nicholas T Olney, Shafeeq Ladha, Namita A Goyal, Thomas Meyer, Michael G Hanna, Colin Quinn, Angela Genge, Lorne Zinman, Duaa Jabari, Christen Shoesmith, Albert C Ludolph, Christoph Neuwirth, Sharon Nations, Jeremy M Shefner, Martin R Turner, Joanne Wuu, Richard Bennett, Hoang Dang, and Claus Sundgreen
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial., Stefan R Bornstein, Dick de Zeeuw, Hiddo J L Heerspink, Friedrich Schulze, Lisa Cronin, Arne Wenz, Katherine Tuttle, Samy Hadjadj, and Peter Rossing
An inconspicuous identification: Isolation and identification of a novel Pichia species presenting as fungemia following cardiac surgery., Allorie T Caldwell, Toni Gabaldón, Verónica Mixão, Nancy L Wengenack, Benjamin P Westley, and Ryan W Stevens
Safety and Efficacy of Empiric De-escalation of Antibiotics for Pneumonia in the Intensive Care Unit, Brandon Carron
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study., Laura C Coates, Proton Rahman, Philip J Mease, May Shawi, Emmanouil Rampakakis, Alexa P Kollmeier, Xie L Xu, Soumya D Chakravarty, Iain B McInnes, and Lai-Shan Tam
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial., Kurt de Vlam, Walter P Maksymowych, Gaia Gallo, Proton Rahman, Philip Mease, Venkatesh Krishnan, Conor J McVeigh, Jeffrey Lisse, Danting Zhu, Rebecca J Bolce, and Philip G Conaghan
Naloxone: From Legislation to Distribution, Kailyn Elliot, Emily Stewart, and John Delfeld
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses., Oliver FitzGerald, Dafna D Gladman, Philip Mease, Christopher Ritchlin, Josef S Smolen, Lu Gao, Yanhua Hu, Miroslawa Nowak, Subhashis Banerjee, and Ian Catlett
Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period., Yeon Mi Hwang, Ryan T Roper, Samantha N Piekos, Daniel A Enquobahrie, Mary F Hebert, Alison G Paquette, Priyanka Baloni, Nathan D Price, Leroy Hood, and Jennifer J Hadlock
A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer., Tiffany Juarez, Jaya Mini Gill, Annie Heng, Jose Carrillo, Naveed Wagle, Natsuko Nomura, Minhdan Nguyen, Judy D Truong, Lucia Dobrawa, Walavan Sivakumar, Garni Barkhoudarian, Daniel F Kelly, and Santosh Kesari
Toxin-Induced Liver Injury and Extracorporeal Treatment of Liver Failure., Angela H Lam and Joshua D King
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study., Bob T Li, Funda Meric-Bernstam, Aditya Bardia, Yoichi Naito, Salvatore Siena, Philippe Aftimos, Ian Churchill Anderson, Giuseppe Curigliano, Maria de Miguel, Maitri Kalra, Do-Youn Oh, Joon Oh Park, Sophie Postel-Vinay, Sun Young Rha, Taroh Satoh, Iben Spanggaard, Flavia Michelini, Ann Smith, Karime Kalil Machado, Cristina Saura, and DESTINY-PanTumor01 study group
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis., Philip Mease, Dafna D Gladman, Joseph F Merola, Peter Nash, Stacy Grieve, Victor Laliman-Khara, Damon Willems, Vanessa Taieb, Adam R Prickett, and Laura C Coates
Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Alexis Ogdie, John Tesser, Natalie J Shiff, Ruizhi Sophia Zhao, Soumya D Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R McLean, Aaron Broadwell, Arthur Kavanaugh, and Joseph F Merola
The intersection of frailty and metabolism., Manish Mishra, Judy Wu, Alice E Kane, and Susan E Howlett
Med rec double check: Inpatient psychiatry medication errors identified on admission using Medicaid Web portals and electronic pharmaceutical claims data., Su Su E Oo and Ian R McGrane
7P Patient-relevant endpoints from PAPILLON: Amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated (Ex20ins) advanced NSCLC, L Paz-Ares, Rachel E Sanborn, and See full list of authors in comments
IV vs PO: The Acetaminophen Showdown at Swedish, Diem Pham, Adam Corson, and Renee Rassilyer-Bomers
Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia., Guangrong Qin, Jin Dai, Sylvia Chien, Timothy J Martins, Brenda Loera, Quy H Nguyen, Melanie L Oakes, Bahar Tercan, Boris Aguilar, Lauren Hagen, Jeannine McCune, Richard Gelinas, Raymond J Monnat, Ilya Shmulevich, and Pamela S Becker
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis., Proton Rahman, Iain B McInnes, Atul Deodhar, Georg Schett, Philip Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, and Dennis McGonagle
Key considerations in navigating ticagrelor's reported effect on heparin-induced thrombocytopenia functional assays in a landscape of limited data., Genene Salman, Herman J Johannesmeyer, and Martin J Breen
Evaluation of Aluminum Exposure in Neonates Receiving Parenteral Nutrition, Emma Sedarski
Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)., Kyle E Smoot, Horia Marginean, Tiffany Gervasi-Follmar, and Chiayi Chen
Chronic use of Antihypertensive Medications and Peak Exercise Blood Pressure in Adult Men and Women from the BALL ST Cohort., Emily Spencer, Mary Imboden, James E Peterman, Mitchell H Whaley, Leonard A Kaminsky, Bradley S Fleenor, and Matthew P Harber
Adherence to SB5195 Naloxone Distribution Requirements at Discharge from the Emergency Department, E Stewart, J Delfeld, J McKay, J Corhei, and Kailyn Elliot
Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: results from a randomized phase 2 trial., Vibeke Strand, Laure Gossec, Laura C Coates, Alexis Ogdie, Jiyoon Choi, Brandon Becker, Joe Zhuo, Thomas Lehman, Miroslawa Nowak, Ayanbola Elegbe, Philip Mease, and Atul Deodhar
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials., Rui Sun, Mercedes Bustamante, Venkatesh Kumar Gurusamy, Mark Lebwohl, Alice B Gottlieb, Philip Mease, Atul Deodhar, Weibin Bao, Meryl Mendelson, Brian Porter, Deepa Chand, and Victor Dong
Safety of Ketamine Use for Rapid Control of Agitation in the Emergency Department, Rosa Hong Trieu
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial., Katherine R Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney, Lisa Cronin, Hiddo J L Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa Rotter, Arnold Silva, Shimoli V Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, Peter Rossing, and ASi in CKD group
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice., Della Varghese, Giovanna I Cruz, Colden Johanson, Liz Toland, Miguel Miranda, Eleanor C Faherty, David Harland, and Henry G Kaplan
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison., Richard B Warren, Iain B McInnes, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, and Philip Mease
Achievement of clinical, endoscopic, and histologic outcomes in patients with ulcerative colitis treated with etrasimod, and association with fecal calprotectin and C-reactive protein: results from the Phase 2 OASIS trial., Andres J Yarur, Michael Chiorean, Julián Panés, Vipul Jairath, Jinkun Zhang, Christopher J Rabbat, William J Sandborn, Séverine Vermeire, and Laurent Peyrin-Biroulet
A new era in the science and care of kidney diseases., Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, Vivek Jha, Carol Pollock, Katherine Tuttle, Peter Kotanko, Andrzej Wiecek, Hans Joachim Anders, Giuseppe Remuzzi, Kamyar Kalantar-Zadeh, Adeera Levin, and Raymond Vanholder
Submissions from 2023
Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma, Marwah Al-Aloosi, Amanda M Prechtl, Payel Chatterjee, Brady Bernard, Christopher J Kemp, Rachele Rosati, Robert L Diaz, Lauren R Appleyard, Shalini Pereira, Alex Rajewski, Amber McDonald, Eva J Gordon, and Carla Grandori
Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease., Radica Z Alicic and Joshua J Neumiller
Vemurafenib- and Cobimetinib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Metastatic Melanoma., Miriam Al-Saedy, Salsabeal Al-Saedy, and Chad Rieck
Impact of Pre-Advanced Pharmacy Practice Experience (APPE) Curriculum on Student Pharmacists' Professional Identity Formation., Jennifer L Bacci, Jasmine S Mangrum, Curtis G Jefferson, Tim Soverns, Gregory Gin, Kaylin Wakuzawa, Sydney Goo, and Peggy Odegard
Removal of Enterococcus susceptibilities in urine isolates across a large integrated health system, Cody Barfuss, Greg Tallman, Brent Footer, and Alyssa B Christensen
Evaluation of infusion wait times after process change for compounding fosaprepitant and pembrolizumab, Heather Beugli and Ian Ingram
Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) in patients with recurrent platinum refractory/resistant ovarian cancer (041), Bruno Bockorny, Steven O'Day, Kim Margolin, Rachel E Sanborn, Timothy S Kristedja, and See all authors in comments
Resolution of stuttering during ketamine treatment: a case report., Dan Bolton, Tegest Hailu, and Christina A Porucznik
ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial., Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait, Jennifer D Son, Kirsten K Edmiston, Constantine Godellas, Marie C Lee, Michael J Carr, Jennifer E Tonneson, Angelena Crown, Rachel B Lancaster, Hannah E Woriax, Cheryl A Ewing, Harrison S Chau, Anne K Patterson, Jasmine M Wong, Michael D Alvarado, Rachel L Yang, Theresa W Chan, Jori B Sheade, Gretchen M Ahrendt, Kelsey E Larson, Kayla Switalla, Todd M Tuttle, Julia C Tchou, Roshni Rao, Nina Tamirisa, Puneet Singh, Rebekah E Gould, Alicia Terando, Candice Sauder, Kelly Hewitt, Akiko Chiba, Laura J Esserman, and Rita Mukhtar
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies., Alexis C Boulter, Barry J Maurer, Meredith Pogue, Min H Kang, Hwangeui Cho, Amanda Knight, C Patrick Reynolds, Donald Quick, Sanjay Awasthi, and David E Gerber
Personalizing prevention: Advances in pharmacotherapy for HIV prevention., Marisa Brizzi, Elizabeth M Sherman, Sarah B Green, Diana N Nowicki, Emily N Drwiega, Melanie R Nicol, Daniel B Chastain, Eric G Sahloff, William R Truong, David Cluck, Melissa E Badowski, Sarah M Michienzi, and Spencer H Durham
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial., Samuel M Brown, Christina E Barkauskas, Birgit Grund, Shweta Sharma, Andrew N Phillips, Lindsay Leither, Ithan D Peltan, Michael Lanspa, Daniel L Gilstrap, Ahmad Mourad, Kathleen Lane, Jeremy R Beitler, Alexis L Serra, Ivan Garcia, Eyad Almasri, Mohamed Fayed, Kinsley Hubel, Estelle S Harris, Elizabeth A Middleton, Macy A G Barrios, Kusum S Mathews, Neha N Goel, Samuel Acquah, Jarrod Mosier, Cameron Hypes, Elizabeth Salvagio Campbell, Akram Khan, Catherine L Hough, Jennifer G Wilson, Joseph E Levitt, Abhijit Duggal, Siddharth Dugar, Andrew J Goodwin, Charles Terry, Peter Chen, Sam Torbati, Nithya Iyer, Uriel S Sandkovsky, Nicholas J Johnson, Bryce R H Robinson, Michael A Matthay, Neil R Aggarwal, Ivor S Douglas, Jonathan D Casey, Manuel Hache-Marliere, J Georges Youssef, William Nkemdirim, Brad Leshnower, Omar Awan, Sonal Pannu, Darragh Shane O'Mahony, Prasad Manian, J W Awori Hayanga, Glenn W Wortmann, Bruno M Tomazini, Robert F Miller, Jens-Ulrik Jensen, Daniel D Murray, Nina A Bickell, Jigna Zatakia, Sarah Burris, Elizabeth S Higgs, Ven Natarajan, Robin L Dewar, Adam Schechner, Nayon Kang, Alejandro Arenas-Pinto, Fleur Hudson, Adit A Ginde, Wesley H Self, Angela J Rogers, Cathryn F Oldmixon, Haley Morin, Adriana Sanchez, Amy C Weintrob, Alexandre Biasi Cavalcanti, Anne Davis-Karim, Nicole Engen, Eileen Denning, B Taylor Thompson, Annetine C Gelijns, Virginia Kan, Victoria J Davey, Jens D Lundgren, Abdel G Babiker, James D Neaton, H Clifford Lane, and ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis., Gerd R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Philip J Mease, and Emma Guttman-Yassky
Identifying Systemic errors in refilling insulin to prevent another hospitalization: An RCA, John Butler, Mikayla Button, Jared Fincher, Rakin Solaiman, and Michael Woodfin
Patient Reported Outcomes Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease., Priscilla C Canals, Alexia G Aguilar, Gregory T Carter, C Miyabe Shields, Andrew Westerkamp, Meg D'Elia, Joy Aldrich, Robert N Moore, Allison T Moore, and Brian J Piper
Direct Oral Anticoagulants and Warfarin Safety in Rural Patients with Obesity., Zachary R Caverley, Ross J Bindler, Pamela Soh, and Sherri Mendelson
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial., Eric X Chen, Jonathan M Loree, Emma Titmuss, Derek J Jonker, Hagen F Kennecke, Scott Berry, Felix Couture, Chaudharry E Ahmad, John R Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Alice C Wei, Dongsheng Tu, and Chris J O'Callaghan
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program., Michael Chiorean, Marco Daperno, Charlie W Lees, Gianluca Bonfanti, Dimitrios Soudis, Irene Modesto, J Jasper Deuring, and Roger A Edwards
Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial., Michael W A Chu, Marc Ruel, Allen Graeve, Marc W Gerdisch, Ralph J Damiano, Robert L Smith, William Brent Keeling, Michael A Wait, Robert C Hagberg, Reed D Quinn, Gulshan K Sethi, Rosario Floridia, Christopher J Barreiro, Andrew L Pruitt, Kevin D Accola, Francois Dagenais, Alan H Markowitz, Jian Ye, Michael E Sekela, Ryan Y Tsuda, David A Duncan, Daniel G Swistel, Lacy E Harville, Joseph J DeRose, Eric J Lehr, John H Alexander, John D Puskas, and PROACT Mitral Investigators
Improving Metabolic Monitoring during Transfers of Care for Psychiatric Patients Discharged from the Inpatient Psychiatric Residency Service on an Antipsychotic Medication – Part 2, Allison Cohen and Anisha Boetel
IV Dexamethasone to Assist with Post Operative Pain and Nausea, Tasha Coumbs
Design, Implementation, and Assessment Approaches Within an Advanced Human Immunodeficiency Virus (HIV) Elective Course., Rustin D Crutchley, Cheyenne Newsome, Li Wei Chen, Debbie Li, Preeyaporn Sarangarm, Amy Min, Dana Bowers, Renier Coetzee, and Kimberly C McKeirnan
ASHP Foundation Pharmacy Forecast 2023: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems., Joseph T DiPiro, Todd W Nesbit, Charles Reuland, Francesca E Cunningham, Pamela Schweitzer, Marie A Chisholm-Burns, Leyner Martinez, Rita Shane, Christopher M Scott, Scott D Nelson, Dara L E Mize, Elva Van Devender, and Lance Oyen
MDR1-EXPRESSING CD4, Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J Campbell, Séverine Metzger, Thomas Duhen, Olivier Trédan, Christophe Caux, and Christine Ménétrier-Caux
A Quasi-Experimental Study of Trough-Guided versus Area under the Curve-Guided Vancomycin Monitoring in Patients with Methicillin Resistant Staphylococcus aureus Bacteremia using Desirability of Outcome Ranking (DOOR), Justin Donat, Brent Footer, and Gregory B. Tallman
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis., Lihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, Jennifer Petkovic, Vibeke Strand, Philip Mease, and Keith Colaco
Optimizing collaboration among clinical pharmacy specialists and behavioral health providers in the primary care setting to increase mental health access, Ryan Ferris, Christine Doran, Bonnie Jiron, and Dara L. Johnson
Abstract 4876: A systems pharmacology approach to discover synergistic targeted therapy combinations, Cameron T. Flower, Chunmei Liu, James R Heath, Wei Wei, and Forest M. White
Retrospective Review of the utility of MRSA NAAT screening to predict MRSA Infections, Nyles T Fowler, Brent Footer, and Caitlin Morris
Warfarin Sensitivity after Valve Replacement Surgery, Jason Frederick, Pamela Levine, and Arezou Naseri
Benzodiazepine-minimizing protocol for alcohol withdrawal: a comparative analysis, Jennifer Gaston, Hsin-Fang Li, Emily J Cox, Caitlin Klamper, and John F Wurzel
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study., Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, Minh D Dao, Emese Zsiros, Renata R Urban, Heidi J Gray, Barbara A Goff, Chirag A Shah, Nikki L Neubauer, James Y Dai, Janos L Tanyi, and John B Liao
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis., Alice B Gottlieb, Iain B McInnes, Proton Rahman, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty, Frederic Lavie, and Philip J Mease
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing., Heidi J Gray, Payel Chatterjee, Rachele Rosati, Lauren R Appleyard, Grace J Durenberger, Robert L Diaz, Hallie A Swan, Danielle Peretti, Maddy Pollastro, Trevor Ainge, Katannya Kapeli, Shalini Pereira, Astrid L Margossian, Kalyan Banda, Barbara A Goff, Elizabeth M Swisher, Brady Bernard, Christopher J Kemp, and Carla Grandori
Factors impacting adherence to antidiabetic medications and health outcomes in diabetes mellitus patients in Medicare populations, Kelli Hoang, Kelly Simpson, and Danny Wallenslager
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study., Le H Hua, Amit Bar-Or, Stanley L Cohan, Fred D Lublin, Patricia K Coyle, Bruce Ac Cree, Xiangyi Meng, Wendy Su, Gina Mavrikis Cox, and Robert J Fox
Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events, Yeon Mi Huang, Ryan Roper, Samantha N. Piekos, Daniel A. Enquobahrie, Mary F. Herbert, Alison G. Paquette, Priyanka Baloni, Nathan D Price, Leroy Hood, and Jennifer J Hadlock
Seizures Following Self-Medication With Colloidal Silver: A Case Report., Daniel Hu and Cary Yuen
DOAC Ambulatory Risk Assessment, Katie Hufft and Cherry Luz P. Tortor
Take-Home Naloxone and Opioid Prescribing Patterns by Provider Specialty Type in Chronic Pain Patients: A Retrospective Study (2023, May) Poster Presented at the American Socierty for Pain and Neurology, D Ile, Alyx Lesko, and See all authors in comments
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors., Antonio Jimeno, Joaquina Baranda, Wade T Iams, Jong Chul Park, Monica Mita, Michael S Gordon, Matthew Taylor, Neesha Dhani, Alexis D Leal, Prakash Neupane, Cathy Eng, Oladapo Yeku, Alain Mita, Justin C Moser, Marcus Butler, Scott M Loughhead, Julia Jennings, Nathan R Miselis, Rui-Ru Ji, Nitya Nair, Martin Kornacker, Ricardo F Zwirtes, Howard Bernstein, and Armon Sharei
Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review., Tanner M Johnson, Thomas F Byrd, Wendi K Drummond, Lindsey M Childs-Kean, Monica V Mahoney, Jeffrey C Pearson, and Christina G Rivera
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy., Saro Kasparian, Oren Wei, Ni-Chun Tsai, Joycelynne Palmer, Sumanta Pal, Yung Lyou, and Tanya Dorff
The impact of pharmacy led education on the management of heart failure with preserved ejection fraction in the primary care setting, Laura Kays, Ben Rosati, Trevor Laursen, and Maurice N. Tran
Response to OKN-007 and NAC in a Patient with Unilateral Hearing Loss and Chronic Tinnitus from Vestibular Schwannoma., Santosh Kesari, Andy Liu, Jaya Mini Gill, Minhdan Nguyen, Judy D Truong, Raffi Nersesian, Emma Chacon, Akanksha Sharma, Naveed Wagle, Chester Griffiths, Gregory Frazer, Max Zats, Shinwook Kang, Matthew B West, Richard D Kopke, and Tiffany Juarez
Activity of pemetrexed in pre-clinical chordoma models and humans., Santosh Kesari, Feng Wang, Tiffany Juarez, Shashaanka Ashili, C Pawan K Patro, Jose Carrillo, Minhdan Nguyen, Judy D Truong, Joan Levy, Josh Sommer, Daniel M Freed, Joanne Xiu, Yuki Takasumi, Eric Bouffet, and Jaya Mini Gill
Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report., Sarah Kim, Nicholas L Stucky, Wendi K Drummond, Fawzy Elbarbry, and Brent Footer
Impact of Geriatric Mini-fellowship on Prescribing Practice of the PMG Primary Care Providers, Madalyn Kuhlenberg and Sharon Leigh
Comparison of clinical diabetes outcomes of patients managed via telemedicine pharmacists during the COVID pandemic relative to continued management by primary care clinics, Trevor Laursen and Stephanie Chan
Standardize to Optimize: A contemplation of Pyxis, inventory, and workflow, Anthony Le and Scott King
Evaluation of standard dose ibuprofen in combination with acetaminophen for patent ductus arteriosus (PDA) treatment in preterm neonates, Jennifer Lee, Samantha Tatz, and Douglas Hanes
Things We Do for No Reason™: Pharmacological sleep aids for hospitalized patients with acute insomnia., August Longino, Odette Zero, and Matthew L Lorenz
Potential Impact of Rapid Antimicrobial Susceptibility Test (rAST) on Providence Oregon Hospitals Currently Without, Andrew Ly and Mark Vance
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia., F Linzee Mabrey, Hui Nian, Chang Yu, Elizabeth M Barnes, Uma Malhotra, Carmen Mikacenic, Julia Goldstein, D Shane O'Mahony, Julia Garcia-Diaz, Patricia Finn, Kirk Voelker, Eric D Morrell, Wesley H Self, Patrice M Becker, Thomas R Martin, and Mark M Wurfel
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia., Anthony R Mato, Jennifer A Woyach, Jennifer R Brown, Paolo Ghia, Krish Patel, Toby A Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S Tam, Nirav N Shah, Catherine C Coombs, Chaitra S Ujjani, Bita Fakhri, Chan Y Cheah, Manish R Patel, Alvaro J Alencar, Jonathon B Cohen, James N Gerson, Ian W Flinn, Shuo Ma, Deepa Jagadeesh, Joanna M Rhodes, Francisco Hernandez-Ilizaliturri, Pier L Zinzani, John F Seymour, Minna Balbas, Binoj Nair, Paolo Abada, Chunxiao Wang, Amy S Ruppert, Denise Wang, Donald E Tsai, William G Wierda, and Wojciech Jurczak
Improving Resident Awareness and Documentation of Abnormal Involuntary Movements in Psychiatric Patients on Antipsychotic Medications, Jocelyn McCornack and Kelly Wurzel
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)., Iain B McInnes, Akihiko Asahina, Laura C Coates, Robert Landewé, Joseph F Merola, Christopher T Ritchlin, Yoshiya Tanaka, Laure Gossec, Alice B Gottlieb, Richard B Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, and Philip Mease
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study., Philip Mease, Arathi Setty, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Mauro Keiserman, Kyle Carter, Yihan Li, Reva McCaskill, Erin McDearmon-Blondell, Peter Wung, and William Tillett
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study., Philip Mease, Arathi Setty, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Mauro Keiserman, Kyle Carter, Yihan Li, Reva McCaskill, Erin McDearmon-Blondell, Peter Wung, and William Tillett
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With, Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez, Eugene R Ahn, Timothy L Cannon, Steven Powell, John C Krauss, Christopher M Reynolds, Margaret von Mehren, Deepti Behl, Carmen J Calfa, Herbert L Duvivier, Henry G Kaplan, Michael B Livingston, Manish R Sharma, Walter Urba, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)., Joseph F Merola, Robert Landewé, Iain B McInnes, Philip Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Alice B Gottlieb, Diamant Thaçi, Richard B Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, and Laura C Coates
Optimizing preclinical models of ageing for translation to clinical trials., Sarah J Mitchell, Michael R MacArthur, and Alice E Kane
Inpatient Management of Medication-Assisted Therapies for Opioid Use Disorder, Tracee Mock, Clara Mikhaeil, and Emily H. Hsu
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial., Bradley J Monk, Krishnansu S Tewari, Coraline Dubot, M Valeria Caceres, Kosei Hasegawa, Ronnie Shapira-Frommer, Pamela Salman, Eduardo Yañez, Mahmut Gümüş, Mivael Olivera Hurtado de Mendoza, Vanessa Samouëlian, Vincent Castonguay, Alexander Arkhipov, Cumhur Tekin, Kan Li, Allison Martin Nguyen, Matthew J Monberg, Nicoletta Colombo, and Domenica Lorusso
